Shares of QuidelOrtho Corporation (QDEL), a diagnostic testing technologies and solutions provider, are rising more than 9% Thursday morning after the company reported preliminary first-quarter revenue, above analysts’ view.
The company expects revenue in the first quarter to be in the range of $840 million to $850 million, driven by strong results in its Labs business as well as better-than-expected results in the Point of Care business.
On average 8 analysts polled by Thomson-Reuters are expecting revenue of $746.75 million for the quarter.
First-quarter results are scheduled to be reported on May 3.
Source: Read Full Article
Lates News:
-
Cryptos Climb Despite A Firm Dollar And Lingering Fed Fears
-
Cryptos Slide After A Brilliant Rally
-
Analyst Predicts 90% Likelihood of SEC Approving Bitcoin Spot ETF by January 2024 or Earlier
-
Ormat Technologies Drops 8% After Pricing Public Offering
-
‘Shark Tank’ Star Explains the Upcoming ‘Mega Opportunity’ for Bitcoin’